592 related articles for article (PubMed ID: 29471249)
1. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
[TBL] [Abstract][Full Text] [Related]
2. S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.
Ondruschka B; Pohlers D; Sommer G; Schober K; Teupser D; Franke H; Dressler J
J Neurotrauma; 2013 Nov; 30(22):1862-71. PubMed ID: 23796187
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids.
Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J
J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Park SH; Hwang SK
World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
[TBL] [Abstract][Full Text] [Related]
5. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Park DW; Park SH; Hwang SK
Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
[TBL] [Abstract][Full Text] [Related]
7. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma resulting from ventricular drain insertion.
Brandner S; Thaler C; Buchfelder M; Kleindienst A
J Neurotrauma; 2013 Jul; 30(13):1205-10. PubMed ID: 23390981
[TBL] [Abstract][Full Text] [Related]
9. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
[TBL] [Abstract][Full Text] [Related]
11. Acute phase response after fatal traumatic brain injury.
Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
[TBL] [Abstract][Full Text] [Related]
12. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
[TBL] [Abstract][Full Text] [Related]
13. Association of CSF biomarkers and secondary insults following severe traumatic brain injury.
Stein DM; Kufera JA; Lindell A; Murdock KR; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
Neurocrit Care; 2011 Apr; 14(2):200-7. PubMed ID: 21210304
[TBL] [Abstract][Full Text] [Related]
14. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.
Rodríguez-Rodríguez A; Egea-Guerrero JJ; Gordillo-Escobar E; Enamorado-Enamorado J; Hernández-García C; Ruiz de Azúa-López Z; Vilches-Arenas Á; Guerrero JM; Murillo-Cabezas F
Neurol Res; 2016 Feb; 38(2):130-7. PubMed ID: 27078699
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
Geyer C; Ulrich A; Gräfe G; Stach B; Till H
J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
17. Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.
Ondruschka B; Woydt L; Bernhard M; Franke H; Kirsten H; Löffler S; Pohlers D; Hammer N; Dreßler J
Int J Legal Med; 2019 May; 133(3):871-881. PubMed ID: 30167776
[TBL] [Abstract][Full Text] [Related]
18. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
[TBL] [Abstract][Full Text] [Related]
19. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.
Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749
[TBL] [Abstract][Full Text] [Related]
20. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
